Found: 33
Select item for more details and to access through your institution.
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The area of residual tumor predicts esophageal squamous cell carcinoma prognosis following neoadjuvant chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4663, doi. 10.1007/s00432-022-04366-7
- By:
- Publication type:
- Article
Safety and Efficacy of Trifluridine/Tipiracil Administered After Anti-PD-1 Therapies for Advanced Gastric Cancer.
- Published in:
- In Vivo, 2023, v. 37, n. 4, p. 1729, doi. 10.21873/invivo.13260
- By:
- Publication type:
- Article
Prognosis of patients with residual pathological disease after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy and surgery for esophageal squamous cell carcinoma: a retrospective cohort study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241229432
- By:
- Publication type:
- Article
ASO Visual Abstract: Prognostic Impact of the Loss of Skeletal Muscle Mass during Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 13, p. 8131, doi. 10.1245/s10434-022-12379-2
- By:
- Publication type:
- Article
Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1649, doi. 10.1007/s10637-021-01125-2
- By:
- Publication type:
- Article
Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1413, doi. 10.1007/s10147-022-02200-1
- By:
- Publication type:
- Article
Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 8, p. 1279, doi. 10.1007/s10147-022-02185-x
- By:
- Publication type:
- Article
Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211009143
- By:
- Publication type:
- Article
Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, v. 13, p. 1, doi. 10.1177/1758835920986518
- By:
- Publication type:
- Article
Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211009143
- By:
- Publication type:
- Article
Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920986518
- By:
- Publication type:
- Article
Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920942377
- By:
- Publication type:
- Article
Comparing GOZILA and COLOMATE: Ongoing Umbrella/Basket Trials Examining Genetic Testing in Gastrointestinal Malignancies.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 7, p. 382, doi. 10.46883/onc.2021.3507.0382
- By:
- Publication type:
- Article
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.576036
- By:
- Publication type:
- Article
REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00263
- By:
- Publication type:
- Article
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 2, p. 283, doi. 10.1038/s41416-024-02730-7
- By:
- Publication type:
- Article
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 6, p. 1032, doi. 10.1038/s41416-023-02378-9
- By:
- Publication type:
- Article
Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer–single institutional experience.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 6, p. 1030, doi. 10.1007/s10120-023-01427-9
- By:
- Publication type:
- Article
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 5, p. 893, doi. 10.1007/s10120-020-01058-4
- By:
- Publication type:
- Article
Definitive chemoradiotherapy induces T-cell-inflamed tumor microenvironment in unresectable locally advanced esophageal squamous cell carcinoma.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 9, p. 798, doi. 10.1007/s00535-024-02120-z
- By:
- Publication type:
- Article
Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05080-x
- By:
- Publication type:
- Article
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 845, doi. 10.1002/onco.13870
- By:
- Publication type:
- Article
Whole‐transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential.
- Published in:
- Cancer Science, 2024, v. 115, n. 5, p. 1622, doi. 10.1111/cas.16109
- By:
- Publication type:
- Article
Impacts of the STING‐IFNAR1‐STAT1‐IRF1 pathway on the cellular immune reaction induced by fractionated irradiation.
- Published in:
- Cancer Science, 2022, v. 113, n. 4, p. 1352, doi. 10.1111/cas.15297
- By:
- Publication type:
- Article
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy.
- Published in:
- Cancer Science, 2022, v. 113, n. 4, p. 1531, doi. 10.1111/cas.15226
- By:
- Publication type:
- Article
CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 7, p. 2915, doi. 10.1111/cas.14926
- By:
- Publication type:
- Article